A detailed history of First Fiduciary Investment Counsel, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, First Fiduciary Investment Counsel, Inc. holds 235,002 shares of PFE stock, worth $6.07 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares
235,002
Previous 250,441 6.16%
Holding current value
$6.07 Million
Previous $7.01 Million 2.94%
% of portfolio
1.36%
Previous 1.52%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$27.7 - $31.39 $427,660 - $484,630
-15,439 Reduced 6.16%
235,002 $6.8 Million
Q2 2024

Aug 07, 2024

SELL
$25.26 - $29.6 $39,658 - $46,472
-1,570 Reduced 0.62%
250,441 $7.01 Million
Q1 2024

Apr 24, 2024

SELL
$25.89 - $29.73 $90,252 - $103,638
-3,486 Reduced 1.36%
252,011 $6.99 Million
Q4 2023

Feb 02, 2024

SELL
$26.13 - $33.94 $269,739 - $350,362
-10,323 Reduced 3.88%
255,497 $7.36 Million
Q3 2023

Nov 07, 2023

BUY
$32.09 - $37.51 $200,626 - $234,512
6,252 Added 2.41%
265,820 $8.82 Million
Q2 2023

Jul 21, 2023

BUY
$36.12 - $41.79 $1.51 Million - $1.75 Million
41,816 Added 19.2%
259,568 $9.52 Million
Q1 2023

May 04, 2023

BUY
$39.39 - $51.28 $509,903 - $663,819
12,945 Added 6.32%
217,752 $8.88 Million
Q4 2022

Feb 07, 2023

SELL
$41.75 - $54.5 $116,774 - $152,436
-2,797 Reduced 1.35%
204,807 $10.5 Million
Q3 2022

Oct 31, 2022

SELL
$43.76 - $53.42 $58,944 - $71,956
-1,347 Reduced 0.64%
207,604 $9.09 Million
Q2 2022

Jul 19, 2022

SELL
$46.53 - $55.17 $144,196 - $170,971
-3,099 Reduced 1.46%
208,951 $11 Million
Q1 2022

Apr 21, 2022

SELL
$45.75 - $56.69 $10 Million - $12.4 Million
-219,382 Reduced 50.85%
212,050 $11 Million
Q4 2021

Jan 14, 2022

SELL
$41.32 - $61.25 $1.17 Million - $1.74 Million
-28,327 Reduced 6.16%
431,432 $25.5 Million
Q3 2021

Oct 07, 2021

SELL
$39.25 - $50.42 $1.15 Million - $1.48 Million
-29,257 Reduced 5.98%
459,759 $19.8 Million
Q2 2021

Jul 29, 2021

SELL
$35.91 - $40.68 $1.58 Million - $1.79 Million
-44,032 Reduced 8.26%
489,016 $19.2 Million
Q1 2021

May 12, 2021

SELL
$33.49 - $37.77 $979,883 - $1.11 Million
-29,259 Reduced 5.2%
533,048 $19.3 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $164,739 - $209,480
-4,922 Reduced 0.87%
562,307 $20.7 Million
Q3 2020

Nov 18, 2020

SELL
$31.75 - $37.25 $268,255 - $314,725
-8,449 Reduced 1.47%
567,229 $20.8 Million
Q2 2020

Aug 10, 2020

BUY
$30.12 - $36.54 $31,927 - $38,732
1,060 Added 0.18%
575,678 $18.8 Million
Q1 2020

May 12, 2020

SELL
$27.03 - $38.62 $55,384 - $79,132
-2,049 Reduced 0.36%
574,618 $18.8 Million
Q4 2019

Feb 12, 2020

BUY
$32.92 - $37.36 $1.57 Million - $1.79 Million
47,819 Added 9.04%
576,667 $22.6 Million
Q3 2019

Nov 15, 2019

BUY
$32.49 - $42.13 $578,646 - $750,335
17,810 Added 3.49%
528,848 $19 Million
Q2 2019

Jul 25, 2019

SELL
$36.98 - $41.52 $2.41 Million - $2.71 Million
-65,221 Reduced 11.32%
511,038 $22.1 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $380,887 - $418,468
-10,157 Reduced 1.73%
576,259 $24.5 Million
Q4 2018

Feb 04, 2019

BUY
$38.47 - $43.86 $32,699 - $37,281
850 Added 0.15%
586,416 $25.6 Million
Q3 2018

Oct 29, 2018

SELL
$34.47 - $41.81 $1.59 Million - $1.92 Million
-45,985 Reduced 7.28%
585,566 $25.8 Million
Q2 2018

Aug 15, 2018

SELL
$32.98 - $35.16 $350,940 - $374,137
-10,641 Reduced 1.66%
631,551 $22.9 Million
Q1 2018

May 03, 2018

BUY
$31.91 - $37.02 $87,082 - $101,027
2,729 Added 0.43%
642,192 $22.8 Million
Q4 2017

Feb 20, 2018

SELL
$33.26 - $35.29 $619,800 - $657,629
-18,635 Reduced 2.83%
639,463 $23.2 Million
Q3 2017

Nov 20, 2017

BUY
$31.0 - $34.15 $34,410 - $37,906
1,110 Added 0.17%
658,098 $23.5 Million
Q2 2017

Aug 15, 2017

BUY
N/A
656,988
656,988 $22.1 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track First Fiduciary Investment Counsel, Inc. Portfolio

Follow First Fiduciary Investment Counsel, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Fiduciary Investment Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Fiduciary Investment Counsel, Inc. with notifications on news.